{"ok":true,"entity":{"id":"resmed","name":"ResMed","entityType":"company","officialName":"Resmed Inc.","canonicalName":"ResMed","displayName":"ResMed","category":"睡眠時無呼吸・呼吸器向け医療機器とデジタルヘルスの企業","shortDescription":"Resmed Inc.（表記はResmed）は、NYSEとASXに上場（ティッカー：RMD）する、米カリフォルニア州サンディエゴ発の医療機器企業で、クラウド接続型のCPAP装置や人工呼吸器、在宅向けソフトウェアを提供します。2026年8月6日に発表した2026年6月期（FY2026）の売上高は約57億ドル（前期比10%増）で、同社は140の国・地域で事業を展開すると説明しています。","primaryCluster":"medical-device","parentEntity":null,"verificationStatus":"draft","website":"https://www.resmed.com/","updatedAt":"2026-10-22T11:50:32.298Z","secondaryClusters":[],"alias":["Resmed Inc.","レスメド"],"searchKeywords":["ResMed","Resmed","レスメド","CPAP","睡眠時無呼吸","sleep apnea","RMD","人工呼吸器","myAir"]},"referenceIndex":["P-01-001","P-02-001","P-04-001","P-05-001","P-06-001"]}